Heading to #AACR24? Don't miss the Bonum team presenting pre-clinical data on our lead program, cLAG3-IL2. For background on our powerful technology platform and the therapeutic potential of cytokines, check out The Bio Report podcast with Bonum's Diane Hollenbaugh and Neela Patel. Listen now: https://ow.ly/FruH50QVUzI Levine Media Group Daniel Levine
Bonum Therapeutics’ Post
More Relevant Posts
-
Join us for Real World Wednesday on February 21, 2024 at 11am EST: The SCOPE 2024 Experience! We attended SCOPE 2024 and we’ll discuss interesting things we saw/heard/learned. If you attended as well, join the discussion on Clubhouse … we’d love to hear of your SCOPE 2024 experience! You can join the conversation here: https://lnkd.in/gybiRKiE Matt Veatch Aaron Kamauu MD MS MPH Kamauu For additional background about SCOPE, listen to the RWW discussion on 16 Feb 2022 with Micah Lieberman & Marina Filshtinsky. Please check-out our website to join the club, get updates and see podcast recordings: https://rwd-rwe.club #scope2024 #realworlddata #rwd #realworldevidence #rwe #datascience #clinicalresearch #drugdevelopment #healthcareanalytics #clinicaltrials #drugdevelopment #medicalinformatics #EHR #electronichealthrecords #EMR #electronicmedicalrecords #operationaldefinitions #computableoperationaldefinitions #computablephenotypes #computablemeasures #measurelibrary #trialtokenization #triallinkage #augmentedtrials #datalinkage
To view or add a comment, sign in
-
“Current signal detection is like guessing that the person you’re speaking to is somewhere between one and two meters tall. That statement is usually very accurate but imprecise”, said Elizabeth Smalley, our VP of Product Management and Data & Analytics during the Life Sciences 360 podcast. Thanks to proactive signal detection, we can track signals more accurately and proactively and create conclusions about various additional drug reactions that patients experience. Learn more about proactive signal detection in the full episode: https://lnkd.in/eQ_6fvMb ##lifesciences #podcast #lifesciences360
To view or add a comment, sign in
-
Endocrine Feedback Loop Podcast | The Cost Effectiveness of Molecular Testing for Indeterminate Thyroid Nodules Listen to Sarah Mayson, MD, and Anupam Kotwal, MD, discuss a recent JCEM article (https://bit.ly/4guF27Y) “Publicly Funded Molecular Testing of Indeterminate Thyroid Nodules: Canada’s Experience.” (https://bit.ly/4e7IN1D) with our host, Chase Hendrickson, MD. "There are some ways where the tests still need improvement in predicting malignancy, but . . . overall, molecular tests have been . . . a game-changer." — Anupam Kotwal, MD Endocrine.org/EFL #JCEM #ThyroidNodules
To view or add a comment, sign in
-
In the first episode of a podcast series focused on alpha-mannosidosis, CheckRare connected with physician assistant Laura Buch, MSPAS, PA-C, to share important insights about the diagnosis and impact of this rare lysosomal storage disorder. Watch a preview of the episode here: https://lnkd.in/ekUn3rYM #AlphaMannosidosis #RareDiseases #ChiesiGlobalRareDiseases
To view or add a comment, sign in
-
Check out our latest Life Sci Talks podcast!
Have you listened to our latest episode of the Life Sci Talks podcast? We're back and featuring Tom Willgoss, Patient-Centered Outcomes Research Chapter Lead, UK Site Head for Data Sciences at Roche and Mark Wade, Global Practice Leader here at TransPerfect Life Sciences! You won't want to miss their important discussion on the significance of patient-centered clinical outcome assessments for endpoint selection in clinical trials, prioritizing diversity and inclusion across global clinical sites, and shifting trends towards DCTs. Keep yourself entertained and in the know by listening to the full episode on Spotify: https://spoti.fi/3L43kXU #LifeSciTalks #ECOA #DecentralizedClinicalTrials
To view or add a comment, sign in
-
🎧 Tune in to our latest podcast episode! 🎙️ Delve into the heart of the EHRA-PATHS Randomized Trial: its aims and significance. Join us as we unpack the importance of this groundbreaking research in revolutionizing atrial fibrillation management. #EHRA #Research #Podcast Listen here: https://lnkd.in/exVgwGcX
To view or add a comment, sign in
-
Equitable access to therapies for all is one of our top priorities as we continue to reimagine the future of clinical trials. Our Chief Product Officer Elisa Cascade shares more on the pharmaphorum podcast, including exclusive insights from our 2023 Study Activation Survey Report. 🎧 Tune into the full episode here: https://lnkd.in/dbUpBcHP #ClinicalResearch #ClinicalTrials #HealthcareInnovation
To view or add a comment, sign in
-
Listen to the podcast of "Defining 'true acid reflux' after peroral endoscopic myotomy for achalasia: a prospective cohort study" by Singh and colleagues. https://lnkd.in/gDCD_cD
To view or add a comment, sign in
-
Did you know: Research reveals that 95% of patients do not participate in clinical trials. How do we find better ways to connect willing and qualified participants to clinical trials? On the Research in Action podcast, Power Co-Founder Brandon Li discusses how we can make access to clinical trials more diverse and patient-friendly. Give the episode a listen: https://lnkd.in/gx8eWaTp #technology
Listen to this podcast on building patient-friendly access to clinical trials
To view or add a comment, sign in
-
🎙 Podcast: Who benefits most from a treatment? On the latest episode of Trial Talk, Peter Godolphin and David Fisher join host Charlotte Hartley to discuss their new 'within-trial framework for subgroup analysis'. Our #MetaAnalysis Group developed this new method to improve how we investigate different treatment effects between different subgroups of patients across multiple clinical trials. 🎧Discover more and tune in to the full episode at https://bit.ly/43boETF #Statistics #StatisticalMethods #ClinicalTrials #MedicalStatistics
To view or add a comment, sign in
4,987 followers
More from this author
-
The Business of Biotech Highlights Bonum CEO John Mulligan & CBO Neela Patel
Bonum Therapeutics 10mo -
A BD Checklist: Best Practices for Partnering with Pharma - by Neela Patel
Bonum Therapeutics 1y -
Developing the Next Generation of Targeted, Conditionally Active Cytokine Therapeutics - by Justin Killebrew
Bonum Therapeutics 1y